ea0070aep672 | Pituitary and Neuroendocrinology | ECE2020
Mallea-Gil Susana
, Diez Sabrina
, Tubert Gloria
, Cuccia Mariela
, Rodriguez Noelia
, Stalldecker Graciela
, de los Angeles Sosa Maria
, Peressotti Bruno
, Palazzo Adriana
, Ballarino Carolina
Giant prolactinomas are tumors with a large size >4 cm and/or prolactin levels higher than 3000 ng/ml and/or highly invasive growth. Today dopamine agonists (DA), mainly cabergoline (CAB), are the first-line choice in the treatment of these tumorsTo assess the efficacy, safety and long-term follow-up of patients with giant prolactinomas treated with DA. We retrospectively reviewed the clinical records of 33 patients with giant prolactinomas. Mea...